Karolinska Institutet Innovations AB

KI Innovations turns promising biomedical research into new products and applications to improve global health and well being. KI Innovations drives the development process by providing project management, funding for patent protection, legal advice, business development and has an extensive network with the international pharmaceutical industry. KI Innovations has reviewed more than 1400 academic innovations, created 40 start-ups and has signed 35 license agreements. KI Innovations has a close collaboration with the Karolinska Development AB.
CEO
Lilian Wikström
We turn medical research into applications for better health and well-being.
  • Category
    Business Development
  • Founded
    1996
  • Public company
    No
  • Number of employees
    8
  • Chairman
    Magnus Persson
  • Principal owners
    Karolinska Institutet Holding AB